2 Volatile Healthcare Stocks

Vital Therapies is laying off 85 employees after halting development of its liver treatment

by Karee Venema

Published on Sep 14, 2018 at 9:50 AM

Shortly before yesterday's close, STAAR Surgical Company (NASDAQ:STAA) said the Food and Drug Administration (FDA) had approved the implantable eye lens maker's Visian Toric ICL lens to correct blurred vision caused by myopia. STAA stock surged 4.1% as a result, and is extending this upside today after a brokerage firm chimed in on the decision.

Canaccord Genuity reiterated its "buy" rating and boosted its price target to $55 from $43, saying Thursday's approval "represents tangible progress for the company along the path of tapping into the large U.S. market opportunity," and the Nov. 1 launch of the product will likely create a catalyst for the firm to raise current guidance. At last check, STAA shares are up 2% to trade at $551.75, and just hit a new record high of $54 out of the gate.

This positive price action has likely caught a number of short sellers off guard. Short interest jumped almost 37% in the latest reporting period to 1.17 million shares -- the most since mid-March. This could create bigger tailwinds for STAA stock, should some of the weaker bearish hands capitulate to its upside momentum.

On the flip side is Vital Therapies Inc (NASDAQ:VTL). VTL stock was last seen down 18.7% at $0.40, matching its record low share price hit this past Wednesday, Sept. 12. While devastating drug data sent the security down nearly 93% two days ago, today's drop comes on the heels of a round of company layoffs. Specifically, Vital Therapies said it has terminated 85 employees after suspending the development of its treatment for liver disease, which will result in a severance cost of $2 million to $2.5 million.

These 2 Airline Stocks are Thanksgiving Week Winners
History suggests both stocks could revisit record highs next week
Keysight Stock Nears Historically Bullish Trendline
KEYS could move after earnings next week
Kohl's Stock Could Catch a Lift Next Week
The stock tends to outperform the week of Black Friday
From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Critical Warning from Rogue Economist
Evidence of a looming financial crisis may be growing, according to Harry Dent.
Natural Gas Prices Spark Heavy Trading on UNG, CHK, and AR
Natural gas ETF UNG is surging to new highs
Downgraded Penny Stock Hits Record Low
The brokerage firm said "compelling" evidence is needed to convince investors
Critical Warning from Rogue Economist
Evidence of a looming financial crisis may be growing, according to Harry Dent.